Day: April 12, 2024

Form 8.5 (EPT/RI) – Centaur Media

Written by Customer Service on April 12, 2024. Posted in Public Companies.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Name of exempt principal trader: Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Centaur Media plc(c) Name of the party to the offer with which exempt principal trader is connected: Investec are Advisor and Joint Broker to Centaur Media plc(d) Date dealing undertaken:11th April 2024(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible...

Enefit Green signed a co-development agreement for early-stage onshore wind projects in Poland

Written by Customer Service on April 12, 2024. Posted in Public Companies.

After market close yesterday, 11 April 2024, Enefit Green’s subsidiary Enefit Green sp. z o.o. signed a Development Service Agreement with a Polish development company – RES Global Investment sp. z o.o. to acquire 100% of development rights in multiple early-stage onshore wind projects in Poland. The signed agreement covers 8 separate early-stage onshore wind projects with targeted total installed capacity of up to 360 MW. The start of construction of these projects is estimated to be no sooner than 2028. According to current expectations the completed projects will operate either under merchant market conditions or a power purchase arrangement to be entered into at the time of investment decision. Total estimated investments amount to ca €80m, which includes the project acquisition cost and other development costs needed to achieve...

Norsk Hydro: Notice of Annual General Meeting 2024

Written by Customer Service on April 12, 2024. Posted in Public Companies.

Notice is given that the Annual General Meeting of Norsk Hydro ASA will be held on Tuesday, May 7, 2024, at 10:00 (CEST). The Annual General Meeting will be held as a hybrid meeting, and shareholders may attend either in person or digitally. It is also possible to vote in advance or attend the meeting by proxy. There is no requirement to register attendance prior to the Annual General Meeting*. Shareholders who wish to attend physically are encouraged to register this within May 3, 2024, at 16:00 CEST. In person participation: The Annual General Meeting will be held at Norsk Hydro ASA’s offices at Vækerø, Drammensveien 260, 0283 Oslo. Digital participation: Please refer to the attached guide for information on online participation, appendix 8. The notice including appendices is attached. All relevant documents may also be found...

CHERY AND FORVIA DEEPEN STRATEGIC PARTNERSHIP WITH A FIRST JOINT VENTURE ON SMART AND SUSTAINABLE COCKPIT

Written by Customer Service on April 12, 2024. Posted in Public Companies.

NANTERRE (FRANCE)APRIL 12th, 2023 CHERY AND FORVIA DEEPEN STRATEGIC PARTNERSHIP WITH A FIRST JOINT VENTURE ON SMART AND SUSTAINABLE COCKPIT On April 11, 2024, in Hefei (China), FORVIA, the world’s seventh-largest automotive technology supplier, announced that it has signed a Joint Venture Agreement with CHERY, a leading Chinese automaker, to deepen mutual cooperation in the field of smart and sustainable cockpit. FORVIA and CHERY will establish a “Cockpit of the Future” Joint Venture Company in Wuhu. This Joint Venture targets to design, develop, manufacture and supply the full cabin scope related systems and modules including seats, interiors and cockpit electronics with low CO2 emission materials and processes. It is the first Joint Venture of that kind in China and will be consolidated by FORVIA with a sales ambition of € 1bn by 2029. It...

Societe Generale Group has reached an agreement with Saham Group for the disposal of Société Générale Marocaine de Banques and la Marocaine Vie

Written by Customer Service on April 12, 2024. Posted in Mergers And Acquisitions.

SOCIETE GENERALE GROUP HAS REACHED AN AGREEMENT WITH SAHAM GROUP FOR THE DISPOSAL OF SOCIÉTÉ GÉNÉRALE MAROCAINE DE BANQUES AND LA MAROCAINE VIE Press releaseParis, 12 April 2024 at 8:00 am Societe Generale Group has signed two contracts with Saham Group, subject to the approval of the competent authorities, with a view for Societe Generale to sell Société Générale Marocaine de Banques including its subsidiaries* and La Marocaine Vie. The two Groups also outlined the framework for a long-term business partnership. Societe Generale’s Board of Directors, which met on 11 April 2024 under the chairmanship of Lorenzo Bini Smaghi, has approved the signing of these contracts which provide for the sale of Societe Generale Group’s shares (57.67%) in Société Générale Marocaine de Banques including its subsidiaries* and the total divestment of Sogecap’s...

RIBER: Strong growth in 2023 full-year earnings

Written by Customer Service on April 12, 2024. Posted in Earnings Releases And Operating Results.

Strong growth in 2023 full-year earnings Revenues: €39.3m (+41%) driven by the robust development of systems (+96%) Operating income: €3.9m, representing 10% of revenues Net income: €3.4m, representing 8.7% of revenues 2024 objectives: continued growth in revenues and earnings Proposed payout of €0.07 per share for 2023 Proposal to simplify the governance structure Bezons, April 12, 2024 – 8:00am – RIBER, the global leader for molecular beam epitaxy (MBE) equipment serving the semiconductor industry, is releasing its full-year earnings for 2023. (€m – at December 31) 2023 2022 ChangeRevenues 39.3 27.8 + €11.4m MBE systems revenues 29.0 14.8 + €14.2m Services and accessories revenues 10.3 13.0 – €2.7mGross margin % of revenues 13.2 33.7% 10.9 39.2%...

Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering

Written by Customer Service on April 12, 2024. Posted in Public Companies.

SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized underwritten public offering of 10,166,667 shares of its common stock at a price to the public of $15.00 per share. In addition, and in lieu of common stock, Nurix is offering to certain investors pre-funded warrants to purchase up to an aggregate of 1,500,100 shares of common stock at a purchase price of $14.999 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. The gross proceeds to Nurix from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Nurix, are expected to be $175.0 million. Nurix has granted the underwriters...

The Keg Royalties Income Fund announces April 2024 cash distribution

Written by Customer Service on April 12, 2024. Posted in Dividend Reports And Estimates.

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced that its April 2024 distribution of $0.0946 per unit has been declared and is payable to unitholders of record as at April 21, 2024. The April 2024 distribution will be paid on April 30, 2023. The Fund is a limited purpose, open-ended trust established under the laws of the Province of Ontario that, through The Keg Rights Limited Partnership, a subsidiary of the Fund, owns certain trademarks and other related intellectual property used by Keg Restaurants Ltd. (“KRL”). In exchange for use of those trademarks, KRL pays the Fund a royalty of 4% of gross sales of Keg restaurants included in the royalty pool. With approximately 10,000 employees, over 100 restaurants and annual system sales exceeding...

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Written by Customer Service on April 12, 2024. Posted in Public Companies.

IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into definitive securities purchase agreements (the “Purchase Agreements”) for the purchase and sale of an aggregate of 5,077,387 shares of common stock, at a purchase price of $ 2.9164 per share of common stock, and pre-funded warrants to purchase 342,888 shares of common stock at a purchase price of $2.9163 per pre-funded warrant (the “Pre-Funded Warrants”). The exercise price of the Pre-Funded Warrants is $0.0001 per share. The private placement was priced “at-the-market” under the rules and regulations of The Nasdaq Stock Market LLC. The private placement is expected to close on or about April 15, 2024, subject to the satisfaction of customary...

Regenx Appoints New Auditor, Extends Rights Offering Expiry Date and Closing of Debenture Offering

Written by Customer Service on April 12, 2024. Posted in Public Companies.

EDMONTON, Alberta, April 11, 2024 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Corporation” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) announced today that it has appointed Gallo LLP, Chartered Professional Accountants, as auditor of Regenx effective April 10, 2024. The resignation of Regenx’s former auditor, Paul J. Rozek Professional Corporation, Chartered Professional Accountant (“PJR Prof Corp.”), was accepted by the Corporation effective April 3, 2024. On April 3, 2024, Regenx was notified by PJR Prof Corp., that the Chartered Professional Accountants of Alberta (“CPA Alberta”) asked PJR Prof Corp. to cease to perform all assurance engagement work on March 18, 2024. Furthermore, Regenx discovered on April 3, 2024, that PJR Prof Corp. signed an undertaking on October 13, 2023, that...

Day: April 12, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice